Abstract |
We demonstrated the effect of clonazepam (2 mg/day) on Meige syndrome in two schizophrenic patients under continuous treatment with antipsychotic drugs, and changes in the plasma levels of gamma-aminobutyric acid ( GABA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol ( MHPG) in these cases. The plasma levels of HVA and MHPG during treatment with clonazepam were decreased in the responder, while not changed in the non-responder to clonazepam. A difference between the responder and the non-responder was not found in the plasma GABA levels. These results suggest that hyperactivities of the central dopaminergic and noradrenergic neurones are involved in the pathophysiology of Meige syndrome.
|
Authors | R Yoshimura, S Kakihara, A Soya, N Ueda, K Shinkai, J Nakamura |
Journal | Psychiatry and clinical neurosciences
(Psychiatry Clin Neurosci)
Vol. 55
Issue 5
Pg. 543-6
(Oct 2001)
ISSN: 1323-1316 [Print] Australia |
PMID | 11555353
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Antipsychotic Agents
- Methoxyhydroxyphenylglycol
- gamma-Aminobutyric Acid
- Clonazepam
- Homovanillic Acid
|
Topics |
- Adult
- Antipsychotic Agents
(adverse effects, therapeutic use)
- Clonazepam
(adverse effects, therapeutic use)
- Female
- Homovanillic Acid
(blood)
- Humans
- Meige Syndrome
(blood, chemically induced, drug therapy)
- Methoxyhydroxyphenylglycol
(blood)
- Schizophrenia, Disorganized
(blood, drug therapy)
- Schizophrenia, Paranoid
(blood, drug therapy)
- gamma-Aminobutyric Acid
(blood)
|